Supreme Court asked to block limits on abortion pill access
A federal appeals court has issued a ruling that restricts the mail-order distribution of the abortion pill Mifepristone. The pharmaceutical company has requested the Supreme Court to intervene. (sources: thehill, foxnews, washingtonpost, bbc, abcnews)
A federal appeals court has blocked the mailing of Mifepristone nationwide, reversing pandemic-era policies. The pharmaceutical company has appealed to the Supreme Court to halt these restrictions.
- The federal appeals court ruling prohibits the prescription of Mifepristone through telehealth services.
- The ruling ends previous allowances for mail-order distribution of the abortion pill.
- The pharmaceutical company has formally requested the Supreme Court to review the appeals court's decision.
Why it matters
The outcome of this legal battle could significantly impact access to abortion medication across the United States.
↓ Why this is on ModernAction
3 bills on this issue are moving right now — and the most active one is To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes..
HR679 · 119th Congress
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What HR679 actually does
This story is about a court ruling that limits mail-order distribution of the abortion pill mifepristone and a request for Supreme Court review. This bill would nullify FDA changes that allowed dispensing outside in-person clinic settings and restore stricter in-person dispensing rules for mifepristone.
If passed, it would:
- Reinstate in-person dispensing requirement for mifepristone • Remove FDA modifications that eased remote dispensing.
2 other bills moving on this issue
Take action on any of them individually.
This story is about a federal appeals court ruling on the distribution of mifepristone and possible follow-up legal proceedings. The bill would remove phrases like “means for procuring abortion” from federal mailability rules, changing how abortion-related items are treated in the mail.
If passed, it would
- Remove abortion-related language from federal mailable matter laws • Narrow nonmailable provisions toward obscene materials.
This story is about Supreme Court asked to halt limits on mail-order abortion pill Mifepristone. This bill would require a physical exam and provider physical presence for medication abortion.
If passed, it would
- Require a physical exam and provider physical presence for medication abortion (with specified exceptions • Create federal criminal penalties for providers who violate the requirements (while exempting patients from.
Top coverage · 11 sources